Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Apellis Pharmaceuticals
Apellis Pharmaceuticals
(APLS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Empaveli
Pegcetacoplan
2021-05-14
2026-2038
Paroxysmal hemoglobinuria
Syfovre
Pegcetacoplan
2023-02-17
2026-2038
Paroxysmal hemoglobinuria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegcetacoplan
wet macular degeneration
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
recurrence
,
kidney diseases
,
iga glomerulonephritis
,
membranous glomerulonephritis
,
lupus nephritis
,
nephritis
,
anemia
,
hemolysis
,
hemolytic anemia autoimmune
,
hemolytic anemia
,
vascular diseases
,
thrombotic microangiopathies
,
macular degeneration
,
paroxysmal hemoglobinuria
,
hemoglobinuria
,
geographic atrophy
,
atrophy
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
,
kidney transplantation
,
neoplasm metastasis
,
chronic kidney failure
,
delayed graft function
Aspartame
leukemia
,
myeloid leukemia
,
ulcerative colitis
,
colitis
,
ulcer
,
rheumatoid arthritis
,
myeloid leukemia acute
,
atopic dermatitis
,
hidradenitis suppurativa
,
eczema
,
dermatitis
,
crohn disease
,
pathologic constriction
,
inflammatory bowel diseases
,
intestinal diseases
Nepidermin
chronic obstructive pulmonary disease
,
respiratory aspiration
,
healthy volunteers/patients
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
triple negative breast neoplasms
,
kidney neoplasms
,
b-cell lymphoma
,
fallopian tube neoplasms
,
follicular lymphoma
,
pancreatic neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
gastrointestinal neoplasms
,
sarcoma
,
urinary bladder neoplasms
,
uterine cervical neoplasms
,
biliary tract neoplasms
,
gallbladder neoplasms
,
carcinoma
,
neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
lymphoma
,
colorectal neoplasms
,
renal cell carcinoma
,
breast neoplasms
,
non-hodgkin lymphoma
,
lung neoplasms
,
hypertension
,
essential hypertension
,
castration-resistant prostatic neoplasms
,
gastrointestinal stromal tumors
,
melanoma
,
recurrence
,
macular edema
,
edema
,
neoplasm metastasis
,
erectile dysfunction
,
large b-cell lymphoma diffuse
,
macular degeneration
,
trichuriasis
,
hookworm infections
,
enterobiasis
,
ancylostomiasis
,
ischemic stroke
,
stroke
,
cerebrovascular disorders
,
transient ischemic attack
,
thromboembolism
,
pharyngitis
,
common cold
,
low back pain
,
back pain
,
acute coronary syndrome
,
syndrome
,
venous thromboembolism
,
atrial fibrillation
,
glioblastoma
,
acne vulgaris
,
dysmenorrhea
,
pneumonia
,
healthcare-associated pneumonia
,
bacterial pneumonia
,
community-acquired pneumonia
,
thyroid neoplasms
,
thyroid diseases
,
retinal diseases
,
wet macular degeneration
,
retinal degeneration
,
eye diseases
,
heart failure
,
exanthema
Decellularized dermal allograft
myelomonocytic leukemia chronic
,
myelodysplastic syndromes
,
preleukemia
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use